Chemotherapy Specialists in MassachusettsPage 3

Ana Garrido-Castro, M.D.

Assistant Professor of Medicine; Director, Triple-Negative Breast Cancer Research, Division of Breast Oncology

Oncology

Narjust Florez, M.D.

Director of the Cancer Care Access Program and a thoracic medical oncologist at the Dana-Farber Brigham Cancer Center. She completed her internal medicine res; Assistant Professor of Medicine, Harvard Medical School

Oncology

Thomas Abrams, M.D.

Assistant Professor of Medicine, Harvard Medical School; Institute Physician

Oncology

Rameen Beroukhim, MD

Associate Professor of Medicine, Harvard Medical School

Oncology

Matthew Yurgelun, M.D.

Director, Lynch Syndrome Center; Senior Physician, Dana-Farber Cancer Institute

Oncology

Marlise Luskin, M.D.

Assistant Professor of Medicine, Harvard Medical School; Senior Physician, Dana-Farber Cancer Institute; Educational Director, Adult Leukemia Program, Dana-Farber Cancer Institute; Associate Program Director, Dana-Farber/Mass General Brigham Hematology/Oncology Fellowship Program

Oncology

Pasi Antero Janne, MD PHD

Senior Vice President for Translational Medicine; Scientific Director, Belfer Center for Applied Cancer Science; Professor of Medicine, Harvard Medical School

Oncology

Robert Lindsley, MD, PHD

Associate Professor of Medicine, Harvard Medical School; Director, Edward P. Evans Center for Myelodysplastic Syndrome; Director of Clinical Genomics in Hematologic Malignancies

Oncology

Vaishali Sanchorawala, M.D.

Skinner Professor of Amyloidosis Research, Department of Medicine, Boston University Chobanian & Avedisian School of Medicine; Director, Amyloidosis Center; Director, Stem Cell Transplantation Program

Oncology

David Kwiatkowski, MD

Professor of Medicine at Harvard Medical School, and Senior Physician at Brigham and Women’s Hospital/Dana-Farber Cancer Institute. He earned a BSc from Caltec; Senior Physician

Oncology

Jeffrey Clark, MD

Associate Professor, Medicine, Harvard Medical School

Oncology

Lecia Sequist, MD

Associate Professor of Medicine, Harvard Medical School; Mary B. Saltonstall Endowed Chair in Oncology, Massachusetts General Hospital Cancer Center

Oncology

Alicia Morgans, MD

Director of the Survivorship Program at Dana-Farber Cancer Institute. A clinician and investigator, she has expertise in clinical trials and patient-reported; Director, Survivorship Program

Oncology

Frank Hodi, MD

Professor of Medicine, Harvard Medical School; Director, Melanoma Center and Center for Immuno-Oncology, Dana-Farber Brigham Cancer Center

Oncology

Craig Bunnell, MD

Chief Medical Officer of the Dana-Farber Cancer Institute, an NCI-designated Comprehensive Cancer Center and Harvard Medical School-affiliated teaching hos; Associate Professor of Medicine at Harvard Medical School. He has been the principal investigator of several institutional and multicenter clinical trials and serves on

Oncology

Justine Cohen, DO

Senior Physician; Assistant Professor of Medicine, Harvard Medical School

Oncology

Haeseong Park, MD

Medical Oncology

Oncology

Lakshmi Nayak, M.D.

Director of the Center for CNS Lymphoma at Dana-Farber Cancer Institute in Boston. She is an Associate Professor of Neurology at Harvard Medical School. She r; Director of the Center for Central Nervous System (CNS) Lymphoma

Oncology

Omar Nadeem, M.D.

Senior Physician, Assistant Professor of Medicine at Harvard Medical School

Oncology

Ephraim Hochberg, MD

Oncology